Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Gynecol Oncol. 2016 Apr;141(1):57–64. doi: 10.1016/j.ygyno.2016.01.004

Table 3. Multivariable Models for Overall Survival and Progression-Free Survival of BRCA wild type OvCa patients with different RAD50 copy number status.

Overall Survival Progression-Free Survival
3-Year Rate, % (95% CI) 5-Year Rate, % (95% CI) HR (95% CI) P Value 3-Year Rate, % (95% CI) 5-Year Rate, % (95% CI) HR (95% CI) P Value
RAD50 status
 RAD50 not deletion 56 (48-64) 22 (15-31) 1 [Reference] 13 (8-22) 8 (4-17) 1 [Reference]
 RAD50 deletion 69 (53-89) 41 (24-70) 0.44(0.25 -0.78) 0.00 5 25 (12-52) 20 (8-47) 0.60(0.37-0.99) 0.044
Tumor Stage
 II 89 (71-100) 67 (36-100) 1 [Reference] 75 (50-100) 38 (9-100) 1 [Reference]
 III 59 (51-68) 21 (14-31) 2.63(0.83-8.30) 0.100 13 (8-21) 8 (4-16) 4.15(1.31-13.12) 0.016
 IV 48 (33-70) 34 (20-58) 2.55(0.76-8.55) 0.131 14 (5-39) 14 (5-39) 4.15(1.23-13.95) 0.022
Age increase of 1.0 ye 1.02(1.00-1.04) 0.011 0.99(0.98-1.01) 0.523